ArticleFrontiers in oncology2021

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.

Miguel J Gil-Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.